NCT01557439View on ClinicalTrials.gov

Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Fasting State
Interventions
DRUG

Levocetirizine Dihydrochloride 5 mg Tablets

A single oral dose of Levocetirizine Dihydrochloride 5 mg Tablets

Trial Locations (1)

380054

Accutest Research Lab (I) Pvt. Ltd., Ahmedabad

Sponsors
All Listed Sponsors
lead

IPCA Laboratories Ltd.

INDUSTRY